Market Cap (In TWD)
1.55 Billion
Revenue (In TWD)
225.46 Million
Net Income (In TWD)
-166.27 Million
Avg. Volume
167.16 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 25.4-43.85
- PE
- -
- EPS
- -
- Beta Value
- 0.845
- ISIN
- TW0004171004
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Grace Chang
- Employee Count
- -
- Website
- https://www.genereach.com
- Ipo Date
- 2012-11-19
- Details
- GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers automatic nucleic acid extraction systems, prep homogenization system, and mini centrifuge equipment; and reagents and consumables, comprising human IVD assays, iiPCR specific reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and research reagents and consumables. The company also provides polymerase chain reaction training programs, molecular diagnostic technical solutions, laboratory installation services, OEM/ODM contract manufacturing services, and research collaboration services. It serves aquaculture, agriculture, food, and human health industries, as well as companion animals and livestock. GeneReach Biotechnology Corp. was founded in 2004 and is headquartered in Taichung, Taiwan.
More Stocks
-
CTPL5
-
FRCOYFast Retailing Co., Ltd.
FRCOY
-
PHSCPHSC plc
PHSC
-
3967Eltes Co.,Ltd.
3967
-
FINGF
-
AMPE
-
7388FP Partner Inc.
7388
-
COTYCoty Inc.
COTY